𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term intermittent administration of interferon-α in patients with chronic non-A, non-B hepatitis

✍ Scribed by Ito, Toshio ;Sue, Kunihiko ;Kakio, Takeshi ;Muguruma, Mitsuru ;Tsuji, Takao ;Teraoka, Tadashi ;Takeda, Sho ;Hironaka, Masatoshi ;Murakami, Kazuharu ;Deguchi, Seigo ;Namba, Yasuo ;Hanahusa, Sumihiro

Publisher
Springer-Verlag
Year
1991
Tongue
English
Weight
823 KB
Volume
26
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C viraemia rebound after “succ
Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non-A, non-B hepatitis
✍ Dr. J. A. Garson; S. Brillanti; C. Ring; P. Perini; M. Miglioli; L. Barbara 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w

Long-term follow-up of patients with chr
Long-term follow-up of patients with chronic hepatitis C treated with α-interferon
✍ Michiko Shindo; Adrian M. di Bisceglie; Jay H. Hoofnagle 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986

Recombinant human α-interferon in patien
Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France
✍ Patrick Marcellin; Nathalie Boyer; Emile Giostra; Claude Degott; Anne Marie Cour 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

We have conducted a multicenter randomized controlled trial comparing two doses of recombinant human a-interferon for efficacy in 60 patients with chronic non-A, non-B hepatitis. The source of infection appeared to be transfusion in 30 patients, intravenous drug abuse in 16 patients and was unknown